At the School of Veterinary Medicine, we aim to inspire and educate veterinary professionals who will advance veterinary medicine to meet the needs of a changing world. We’re home to world-class ...

South Africans – particularly Gauteng residents – have been complaining about a “fly invasion” in recent weeks. But is there any truth to the pest plague? On social media, South Africans ...

Planes that fly faster than the speed of sound create thunderous supersonic booms. But with NASA's X-59 plane, that could change. The space agency plans for the aircraft's first flight in 2025, an ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

Everyone in Philadelphia would be a spelling bee champion if the final word was "eagles." Well, maybe not everyone. Sorry, Rachel Platten but the Eagles' fight song ...

As a growing number of vet clinics across the country are being bought up by international corporations, some independently-owned clinics in London are choosing to stay private — despite offer ...

Performances in N.Y.C. Advertisement Supported by Once used to frequent rejection letters, Blue has become a regular on major stages and is singing the title role in “Aida” at the Metropolitan ...

More than 5,000 years ago, in ancient Egypt, a mixture of silica, lime, copper, and an alkali was heated, resulting in a bright blue compound known as calcium copper silicate. This striking, vibrant ...

When Maja Terzic brought her sick cat to the vet, she agreed to a few hundred dollars in blood work to hopefully find out what was wrong with him. Guppy was then whisked away to a back room.

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...